Loading…
Early cardiovascular events and cardiovascular death after renal transplantation: role of pretransplant risk factors
Background The purpose of this study was to verify the risk factors present in patients on the kidney transplant waiting list that may interfere with the incidence of cardiovascular (CV) events and death during the first 12 months after transplantation. Methods Based on the data collected prospectiv...
Saved in:
Published in: | Clinical and experimental nephrology 2021-05, Vol.25 (5), p.545-553 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
The purpose of this study was to verify the risk factors present in patients on the kidney transplant waiting list that may interfere with the incidence of cardiovascular (CV) events and death during the first 12 months after transplantation.
Methods
Based on the data collected prospectively during pretransplant workups
,
a retrospective study was conducted including 665 patients followed up until death or completing 12 months posttransplantation. Endpoints were the composite incidence of CV events and death.
Results
The prevalence of diabetes, LV hypertrophy, and CV disease at baseline was high; 14% of patients had angina, 26% an abnormal myocardial scan, and 47% coronary artery disease. CV events occurred in 53 patients (8.4%) and in 29 (55%) caused death. The independent predictors of events were age ≥ 50 years (HR 2.292; CI% 1.093–4.806), angina (HR 1.969; CI% 1.039–3.732), and altered myocardial scan (HR 1.905, CI% 1.059–3.428). Altered myocardial scan (HR 2.822, 95% CI 1.095–6.660) was also one of the independent predictor of CV death.
Conclusion
The incidence of CV events and death were predicted by variables associated with myocardial ischemia, a potentially modifiable risk factor. Patients with pretransplantation myocardial ischemia should be considered at a higher risk of developing early CV complications and managed accordingly before, during, and after kidney transplantation. |
---|---|
ISSN: | 1342-1751 1437-7799 |
DOI: | 10.1007/s10157-021-02019-6 |